Armata Pharmaceuticals (ARMP) Profit After Tax (2016 - 2018)
Historic Profit After Tax for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q4 2018 value amounting to -$1.1 million.
- Armata Pharmaceuticals' Profit After Tax rose 5318.88% to -$1.1 million in Q4 2018 from the same period last year, while for Dec 2018 it was -$9.4 million, marking a year-over-year increase of 2685.0%. This contributed to the annual value of -$18.9 million for FY2024, which is 7260.34% up from last year.
- Per Armata Pharmaceuticals' latest filing, its Profit After Tax stood at -$1.1 million for Q4 2018, which was up 5318.88% from -$2.8 million recorded in Q3 2018.
- In the past 5 years, Armata Pharmaceuticals' Profit After Tax registered a high of $21.2 million during Q3 2014, and its lowest value of -$14.5 million during Q1 2015.
- For the 5-year period, Armata Pharmaceuticals' Profit After Tax averaged around -$848526.3, with its median value being -$2.4 million (2016).
- Over the last 5 years, Armata Pharmaceuticals' Profit After Tax had its largest YoY gain of 19474.15% in 2014, and its largest YoY loss of 58735.56% in 2014.
- Quarter analysis of 5 years shows Armata Pharmaceuticals' Profit After Tax stood at -$664000.0 in 2014, then plummeted by 235.99% to -$2.2 million in 2015, then plummeted by 325.82% to -$9.5 million in 2016, then soared by 75.24% to -$2.4 million in 2017, then skyrocketed by 53.19% to -$1.1 million in 2018.
- Its last three reported values are -$1.1 million in Q4 2018, -$2.8 million for Q3 2018, and -$3.2 million during Q2 2018.